Category Archives: Uncategorized

New Study: Genetic testing for inherited mutations may be helpful for all people with advanced or metastatic cancer

In a study of nearly 12,000 cancer patients with a variety of cancers, eight percent of participants with metastatic cancer had an inherited mutation in a cancer gene that qualified them for a targeted treatment or for participation in a clinical trial. The majority of people with metastatic cancer were unaware that they had an inherited mutation, and had not receive gene-directed treatment to which their tumor may have responded. Of the study participants, 17% tested positive for an inherited mutation in a gene linked to cancer and a potential treatment based on genetic test results existed for 10% of patients in this study. The most commonly found mutation were one of the two BRCA genes. The study authors suggest that genetic testing for inherited mutations may be warranted for all patients with advanced or metastatic cancer. To learn more and read further into this study, please click here:


“Beyond Angelina Jolie: Diagnosis and Management of Hereditary Breast and Ovarian Cancer Syndrome”

Family Physician Webinar: “Beyond Angelina Jolie: Diagnosis and Management of Hereditary Breast and Ovarian Cancer Syndrome”

BRCAinBC’s Dr. Rona Cheifetz MD FRCSC Surgical Oncology at BC Cancer’s Hereditary Cancer Program and Dr. Lesa Dawson MD FRCSC BC Gynecologic Oncology Cancer Survivorship Clinic presented this informative and well-received webinar on September 16, 2021 as part of BC Cancer’s Continuing Medical Education Program. The webinar is intended to help BC’s physicians 1) Identify the features of family history and ethnic background that influence hereditary risk; 2) Describe the ovarian and breast cancer risk management options for BRCA mutation carriers; and 3) Cite the management of other cancer risks associated with BRCA mutations.

Please click on the link below to view the webinar.


New BRCA Research Opportunities for Men

 The National Institutes of Health (NIH) is seeking male participants (30-75) with a genetic risk factor for developing prostate cancer. The study includes regular MRI screening and biopsies for those showing irregular tests. For more information, please contact Anna Couvillon at the National Institutes of Health.





Graphic Novel Study

Are you a male at high risk for developing hereditary cancer but has not been diagnosed with cancer? Do you have a family history of carrying a BRCA1/2 genetic mutation? Do you feel you have information to make informed health and family decisions about your future? Are you interested in sharing your experiences to help others?

Participate in a 60-minute online interview. Participants will receive a $30 Amazon gift card. If you are interested in this research opportunity, please the study coordinator Ms. Lexi Ingle at